| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Perspective Therapeutics, Inc. (CATX) has 8 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. CATX is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 735.0K | $2.75M | - | |
| CFO | 600.0K | $2.24M | - | |
| Other | 150.0K | $561.0K | - | |
| Other | 90.0K | $336.6K | - | |
| Dir | 75.0K | $280.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 13, 2025 | Hunt Jonathan Robert61 | Chief Accounting Officer | Buy | 11,000 | $2.03 | $22,294.80 | +22.5% | +135.7% | - | |
| Nov 12, 2025 | Williamson Robert F III63 | Director | Buy | 9,498 | $2.10 | $19,945.80 | +2,595% | +123.6% | - | |
| Mar 31, 2025 | Woods Lori A70 | Director | Buy | 23,475 | $2.13 | $49,999.40 | +14.7% | +61.5% | +95.8% | |
| Mar 31, 2025 | Williamson Robert F III63 | Director | Buy | 60,337 | $2.19 | $132,151.09 | +50.5% | +61.5% | +95.8% | |
| Mar 28, 2025 | Spoor Johan M. | Chief Executive Officer | Buy | 26,676 | $2.24 | $59,672.62 | +71.4% | +64.5% | +85.0% | |
| Mar 28, 2025 | Graham Juan81 | Chief Financial Officer | Buy | 33,333 | $2.25 | $74,945.92 | +1,649% | +64.5% | +85.0% | |
| Dec 4, 2024 | Spoor Johan M. | CEO | Buy | 8,000 | $3.77 | $30,132.00 | +28.3% | -36.7% | -35.6% | |
| Dec 4, 2024 | Henson Heidi | Director | Buy | 25,975 | $3.85 | $100,003.75 | New | -36.7% | -35.6% | |
| Nov 25, 2024 | Williamson Robert F III63 | Director | Buy | 6,266 | $3.64 | $22,813.51 | +0.7% | -26.0% | -40.7% | |
| Nov 25, 2024 | Hunt Jonathan Robert61 | Chief Financial Officer | Buy | 12,829 | $3.82 | $48,974.26 | +8.7% | -26.0% | -40.7% |